1Professor, Department of General Surgery, SBKS Medical Institute and Research Centre, Vadodara
2Associate Professor, Department of General Surgery, SBKS Medical Institute and Research Centre, Vadodara
3Medical Services, Glenmark Pharmaceuticals Ltd., Mumbai
*Corresponding author email: anoophajare@gmail.com
Online published on 20 October, 2014.
Urinary tract infection (UTI) is a global problem which has increased the morbidity and mortality in both men and women. Strategies which are proposed in the management of UTIs include the use of empirical antibiotics with a broader spectrum of coverage. Urine specimen culture is of significant importance to evaluate the organism responsible in the pathogenesis. Garenoxacin, a newer fluoroquinolone with unique structural advantage appears to a suitable drug in the treatment of UTIs.
Urinary tract infection, Garenoxacin, fluoroquinolone, PK/PD, E.coli
